Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse

Magnetic Resonance in Medicine

Volumn 55, Issue 5, 2006, Pages 1170-1174

  Mulder, Willem J M ^a   Douma, Kim ^b   Koning, Gerben A ^c   Van Zandvoort, Marc A ^b   Lutgens, Esther ^b   Daemen, Mat J ^b   Nicolay, Klaas ^a   Strijkers, Gustav J ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

ApoE KO; Atherosclerosis; Contrast agent; Liposome; Molecular MRI; Mouse

Indexed keywords

DISEASES; MAMMALS; PARAMAGNETISM;

APOE-KO; ATHEROSCLEROSIS; CONTRAST AGENT; MOLECULAR MRIS; MOUSE;

LIPOSOMES;

1,2 DISTEAROYL GLYCERO 3 PHOSPHOCHOLINE; 1,2 DISTEAROYL GLYCERO 3 PHOSPHOETHANOLAMINE; APOLIPOPROTEIN E; CHOLESTEROL; CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE BIS(STEARYLAMIDE); LIPOSOME; MACROGOL 2000; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLACK BLOOD MAGNETIC RESONANCE IMAGING; BLOOD VESSEL WALL; CAROTID ARTERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; INTIMA; KNOCKOUT MOUSE; MOUSE; NECK; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TECHNIQUE; VASCULAR LESION;

EID: 33646460434     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.20883     Document Type: Article

References (21)

1. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2000;104:503-516.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
3. Yuan C, Kerwin WS. MRI of atherosclerosis. J Magn Reson Imaging 2004;19:710-719.
4. Fayad ZA, Fuster V. The human high-risk plaque and its detection by magnetic resonance imaging. Am J Cardiol 2001;88:42E-45E.
5. Clarke SE, Hammond RR, Mitchell JR, Rutt BK. Quantitative assessment of carotid plaque composition using multicontrast MRI and registered histology. Magn Reson Med 2003;50:1199-1208.
6. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932-938.
7. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ, Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation 1998;98:1541-1547.
8. Manka DR, Gilson W, Sarembock I, Ley K, Berr SS. Noninvasive in vivo magnetic resonance imaging of injury-induced neointima formation in the carotid artery of the apolipoprotein-E null mouse. J Magn Reson Imaging 2000;12:790-794.
9. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001;89:305-316.
10. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003;107:2453-2458.
11. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415-422.
12. Barkhausen J, Ebert W, Heyer C, Debatin JF, Weinmann HJ. Detection of atherosclerotic plaque with Gadofluorine-enhanced magnetic resonance imaging. Circulation 2003;108:605-609.
13. Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, Weinmann HJ, Fuster V, Toussaint JF, Fayad ZA. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 2004;109:2890-2898.
14. Mulder WJ, Strijkers GJ, Griffioen AW, van Bloois L, Molema G, Storm G, Koning GA, Nicolay K. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 2004;15:799-806.
15. Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001;74:47-61.
16. Rouser G, Fkeischer S, Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970;40:123-128.
17. Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum 2003;48:2059-2066.
18. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005;96:327-336.
19. Sipkins DA, Gijbels K, Tropper FD, Bednarski M, Li KC, Steinman L. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol 2000;104:1-9.
20. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003;108:2270-2274.
21. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-160.